Mohammadreza Nikmaneshi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Biological | 4 | 2020 | 9582 | 0.670 |
Why?
|
Models, Cardiovascular | 2 | 2021 | 996 | 0.640 |
Why?
|
Neoplasms | 7 | 2024 | 21675 | 0.610 |
Why?
|
Angiogenesis Inhibitors | 3 | 2023 | 2037 | 0.600 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3583 | 0.590 |
Why?
|
Pseudopodia | 1 | 2017 | 172 | 0.590 |
Why?
|
Cytosol | 2 | 2017 | 901 | 0.590 |
Why?
|
Neovascularization, Pathologic | 3 | 2023 | 2638 | 0.570 |
Why?
|
Myosins | 1 | 2017 | 409 | 0.550 |
Why?
|
Mechanotransduction, Cellular | 1 | 2020 | 541 | 0.510 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 13691 | 0.500 |
Why?
|
Metabolic Diseases | 1 | 2020 | 658 | 0.450 |
Why?
|
Actins | 2 | 2017 | 2121 | 0.430 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2217 | 0.350 |
Why?
|
Cell Movement | 2 | 2017 | 5216 | 0.290 |
Why?
|
Systems Biology | 2 | 2021 | 470 | 0.290 |
Why?
|
Liver | 1 | 2020 | 7479 | 0.240 |
Why?
|
Models, Theoretical | 3 | 2022 | 3587 | 0.170 |
Why?
|
Ammonia | 1 | 2020 | 239 | 0.170 |
Why?
|
Models, Immunological | 1 | 2022 | 527 | 0.170 |
Why?
|
Hep G2 Cells | 1 | 2020 | 393 | 0.170 |
Why?
|
Cichlids | 1 | 2017 | 11 | 0.160 |
Why?
|
Goldfish | 1 | 2017 | 65 | 0.160 |
Why?
|
Urea | 1 | 2020 | 450 | 0.160 |
Why?
|
Immunotherapy | 2 | 2023 | 4437 | 0.150 |
Why?
|
Albumins | 1 | 2020 | 568 | 0.150 |
Why?
|
Shear Strength | 1 | 2017 | 165 | 0.150 |
Why?
|
Actomyosin | 1 | 2017 | 111 | 0.150 |
Why?
|
Porosity | 1 | 2017 | 360 | 0.140 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2020 | 289 | 0.140 |
Why?
|
Mathematical Concepts | 1 | 2015 | 63 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1988 | 0.130 |
Why?
|
Carbon Dioxide | 1 | 2020 | 1150 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 567 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 516 | 0.130 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1070 | 0.120 |
Why?
|
Rheology | 1 | 2015 | 345 | 0.120 |
Why?
|
Lipoproteins, LDL | 1 | 2017 | 642 | 0.120 |
Why?
|
Coronary Stenosis | 1 | 2020 | 833 | 0.120 |
Why?
|
Blood Vessels | 1 | 2020 | 1124 | 0.120 |
Why?
|
Hepatocytes | 1 | 2020 | 1211 | 0.110 |
Why?
|
Species Specificity | 1 | 2017 | 2480 | 0.110 |
Why?
|
Cytoplasm | 1 | 2017 | 1536 | 0.110 |
Why?
|
Stress, Mechanical | 1 | 2017 | 1684 | 0.110 |
Why?
|
Coronary Vessels | 2 | 2020 | 3106 | 0.090 |
Why?
|
Cell Survival | 1 | 2020 | 5881 | 0.090 |
Why?
|
Computer Simulation | 3 | 2021 | 6188 | 0.090 |
Why?
|
Disease Progression | 3 | 2021 | 13273 | 0.090 |
Why?
|
Oxygen | 1 | 2020 | 4189 | 0.080 |
Why?
|
Glucose | 1 | 2020 | 4398 | 0.080 |
Why?
|
Humans | 13 | 2024 | 743811 | 0.080 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10179 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19894 | 0.060 |
Why?
|
Animals | 4 | 2021 | 168660 | 0.060 |
Why?
|
Algorithms | 1 | 2020 | 13869 | 0.040 |
Why?
|
Hypertension | 1 | 2017 | 8480 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1978 | 0.030 |
Why?
|
Vaccination | 1 | 2024 | 3275 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3175 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2021 | 2961 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4197 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7908 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5170 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7324 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15067 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16674 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9272 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16361 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15526 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81154 | 0.010 |
Why?
|
Aged | 1 | 2022 | 163178 | 0.010 |
Why?
|
Male | 1 | 2022 | 349776 | 0.000 |
Why?
|
Female | 1 | 2022 | 380020 | 0.000 |
Why?
|